Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

A Fifa divulgou mais alguns detalhes do novo modelo do Mundial de Clubes. Agora, são conhecidos o logo oficial da competição, 30 dos 32 classificados e as datas nas quais devem acontecer os ...

Bagmatic NOVO is our new blood collection monitor serving the special needs of mobile blood donations. As a light weight device with outstanding long battery life, it is developed to take a ...

Também recebeu uma grade frantal maior, com listras mais agressivas. Por fim, leva o novo logo da Peugeot, que deixa de ser o leão de corpo inteiro para priorizar um busto. Esse novo logo ...

DSV A/S’s new acquisition, the $15.9 billion takeover of DB Schenker, will almost double the freight company’s sales, making it Denmark’s second-largest firm by that measure and pushing Novo ...

"Gustavo Pimenta assume como CEO da Vale em 2025" Gustavo Pimenta é o novo CEO da Vale ... de Bartolomeo estava perto do fim, Ometto logo indicou Luiz Henrique Guimarães, CEO da Cosan, como ...

Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition ...

A contract manufacturing drug organization executive said he believes that Novo Nordisk's (NVO) planned purchase of Catalent (NYSE:CTLT) will spur competition. Beau Garrett, CEO of American ...

It also provides other contract manufacturing services. Novo Holdings, the investment firm that has a controlling interest in Novo Nordisk, signed a $16.5 billion deal to buy Catalent in February ...

Novo Nordisk A/S’s Wegovy reduced deaths and illness from Covid in a large study that took place during the pandemic, more evidence of the blockbuster shot’s benefits beyond weight loss.

(RTTNews) - Novo Nordisk A/S (NVO) has shared groundbreaking findings at the European Association for the Study of Diabetes meeting in Madrid regarding the potential effectiveness of Saxenda ...